Halozyme Therapeutics, Inc. (NASDAQ:HALO) Short Interest Down 5.4% in October
Halozyme Therapeutics, Inc. (NASDAQ:HALO - Get Rating) was the target of a significant decrease in short ...
Read moreHalozyme Therapeutics, Inc. (NASDAQ:HALO - Get Rating) was the target of a significant decrease in short ...
Read more© 2022 TheDailyStock.News